Statistics from Altmetric.com
This letter is inspired by the ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update’.1
There is no question that we are in full agreement with the overarching principles of the EULAR recommendations. What goes against our principles, however, is the tone of the bullet points. …
Contributors All co-authors have contributed to this letter and agree with its contents.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.